- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Anti-SARS-CoV-2 Infection in Korea, Republic of
Total 100 results
-
Genexine, Inc.CompletedSARS-CoV-2Korea, Republic of
-
GeneOne Life Science, Inc.Active, not recruiting
-
Genexine, Inc.Active, not recruitingSARS-CoV-2Korea, Republic of
-
Genexine, Inc.Active, not recruitingSARS-CoV-2Korea, Republic of
-
International Vaccine InstituteInovio Pharmaceuticals; Coalition for Epidemic Preparedness InnovationsCompletedCoronavirus Infection | SARS-CoV 2Korea, Republic of
-
CelltrionCompletedSARS-CoV-2 InfectionKorea, Republic of
-
CelltrionCompletedSARS-CoV-2 InfectionKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.TerminatedCovid19 | SARS-COV-2 InfectionKorea, Republic of
-
ModernaTX, Inc.RecruitingSARS-CoV-2Korea, Republic of
-
CelltrionCompletedSARS-CoV-2 InfectionKorea, Republic of
-
Quratis Inc.Active, not recruitingCOVID-19 | SARS-CoV-2Korea, Republic of
-
PfizerActive, not recruitingCOVID-19 | SARS-CoV-2 | Adverse Effects | Safety | VaccinesKorea, Republic of
-
Korea University Guro HospitalRecruitingCovid-19 | SARS-CoV-2 | Vaccine | Microbiome | ImmunogenicityKorea, Republic of
-
GeneOne Life Science, Inc.Active, not recruitingSARS-CoV Infection | PneumonitisKorea, Republic of, Puerto Rico, United States, Bulgaria, North Macedonia
-
Dr. Ferrer BioPharmaClinica Union Medica Del Norte, S.A.S., Santiago, República DominicanaActive, not recruitingAccelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Analysis (ACCROS-R)COVID-19 | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Respiratory Infection | SARS CoV 2 Infection | COVID-19 PandemicDominican Republic
-
Intron Biotechnology, Inc.CompletedHealthy Volunteers | Anti-Bacterial Agents | Methicillin-Resistant Staphylococcus Aureus | Methicillin-Sensitive Staphylococcus Aureus InfectionKorea, Republic of
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV2 InfectionUnited States, Puerto Rico
-
AstraZenecaCompletedSARS-CoV-2United States, Belgium, United Kingdom, Brazil, Germany
-
ModernaTX, Inc.Biomedical Advanced Research and Development AuthorityActive, not recruitingSARS-CoV-2United States, Dominican Republic
-
ModernaTX, Inc.Recruiting
-
ModernaTX, Inc.RecruitingSARS-CoV-2United States, Puerto Rico
-
ModernaTX, Inc.National Institute of Allergy and Infectious Diseases (NIAID); Biomedical Advanced...Completed
-
Asan Medical CenterSeoul Business AgencyRecruitingPharmacokinetics | General Surgery | Anti-bacterial AgentsKorea, Republic of
-
Gilead SciencesApproved for marketingSARS-CoV2 InfectionUnited States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
-
Intron Biotechnology, Inc.CompletedHealthy Volunteers | Anti-Bacterial Agents | Methicillin-Resistant Staphylococcus AureusKorea, Republic of
-
Asan Medical CenterCompletedKidney Transplantation RecipientsKorea, Republic of
-
Asan Medical CenterCompletedBone Marrow TransplantationKorea, Republic of
-
Institute of Tropical Medicine, BelgiumInstitut National de Recherche Biomédicale. Kinshasa, République Démocratique...CompletedSARS-CoV Infection | SeroprevalenceCongo, The Democratic Republic of the
-
Yae-Jean KimMiltenyi Biotec B.V. & Co. KGWithdrawnCytomegalovirus InfectionsKorea, Republic of
-
Seoul National University HospitalCompletedTuberculosis, PulmonaryKorea, Republic of
-
Asan Medical CenterCompletedNon-HIV Patients With Pneumocystis Jiroveci PneumoniaKorea, Republic of
-
Children's National Research InstituteRecruitingSARS-CoV-2 InfectionUnited States
-
Seoul National University HospitalUnknownPulmonary Tuberculosis | Mycoplasma PneumoniaKorea, Republic of
-
Intron Biotechnology, Inc.TerminatedAnti-Bacterial Agents | Staphylococcus Aureus BacteremiaKorea, Republic of
-
Asan Medical CenterSuspendedCoronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Mild to Moderate COVID-19Korea, Republic of
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
PfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
Regeneron PharmaceuticalsCompletedHealthy ParticipantsUnited States, Moldova, Republic of, Romania
-
Yonsei UniversityUnknownChronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 DiabetesKorea, Republic of
-
NovavaxBill and Melinda Gates FoundationCompletedCOVID-19 | SARS-CoV-2 InfectionSouth Africa
-
Seoul National University HospitalLG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
CONRADUnited States Agency for International Development (USAID); Agility Clinical...CompletedContraceptive Usage | Anti-Infective Agents | Anti-Retroviral AgentsDominican Republic, United States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV-2 InfectionUnited States
-
MedicagoActive, not recruitingSARS-CoV-2 InfectionUnited States, Canada, United Kingdom, Argentina, Brazil, Mexico
-
National Institute of Allergy and Infectious Diseases...Teva Pharmaceutical Industries, Ltd.TerminatedCOVID-19 | SARS-CoV 2United States
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)Active, not recruitingA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 Infection | Maternal ImmunizationUnited States, United Kingdom, Spain, Brazil, South Africa
-
PfizerActive, not recruitingCOVID-19 | Influenza, Human | SARS-CoV-2 InfectionUnited States
-
BioNTech SEPfizerCompletedSARS-CoV-2 Infection, COVID-19United States, Spain, Finland, Poland, Mexico, Brazil
-
George Washington UniversityCompletedCovid19 | Infectious Disease | SARS-CoV InfectionUnited States